Donald Dixon Sells 40,000 Shares of Amprius Technologies (NYSE:AMPX) Stock

Amprius Technologies, Inc. (NYSE:AMPX) Director Donald Dixon sold 40,000 shares of the company’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $19.13, for a total transaction of $765,200.00. Following the transaction, the director directly owned 444,380 shares of the company’s stock, valued at $8,500,989.40. This represents a 8.26% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Amprius Technologies Stock Performance

Shares of AMPX opened at $16.30 on Friday. The company has a 50-day simple moving average of $18.55 and a 200-day simple moving average of $14.34. The firm has a market capitalization of $2.31 billion, a P/E ratio of -54.33 and a beta of 2.12. Amprius Technologies, Inc. has a 52 week low of $3.43 and a 52 week high of $24.23.

Amprius Technologies (NYSE:AMPX) last announced its quarterly earnings data on Wednesday, May 6th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). The company had revenue of $28.54 million for the quarter, compared to analyst estimates of $25.72 million. Amprius Technologies had a negative net margin of 43.98% and a negative return on equity of 17.48%. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. As a group, equities analysts forecast that Amprius Technologies, Inc. will post -0.07 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. B. Riley Financial upped their price objective on shares of Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, March 9th. Needham & Company LLC reissued a “buy” rating and issued a $20.00 price target on shares of Amprius Technologies in a research report on Tuesday, March 10th. Cantor Fitzgerald increased their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Clear Str started coverage on shares of Amprius Technologies in a research report on Tuesday, June 2nd. They issued a “strong-buy” rating and a $33.00 price target for the company. Finally, Northland Securities set a $24.00 price target on shares of Amprius Technologies in a research report on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $21.67.

Institutional Investors Weigh In On Amprius Technologies

Several large investors have recently made changes to their positions in the company. Janus Henderson Group PLC grew its holdings in shares of Amprius Technologies by 35.2% in the 1st quarter. Janus Henderson Group PLC now owns 52,803 shares of the company’s stock worth $889,000 after purchasing an additional 13,750 shares during the last quarter. Amundi increased its holdings in shares of Amprius Technologies by 17.3% during the first quarter. Amundi now owns 164,589 shares of the company’s stock worth $2,775,000 after buying an additional 24,283 shares in the last quarter. California State Teachers Retirement System increased its holdings in shares of Amprius Technologies by 48.2% during the first quarter. California State Teachers Retirement System now owns 159,903 shares of the company’s stock worth $2,696,000 after buying an additional 51,973 shares in the last quarter. Royal Bank of Canada increased its holdings in shares of Amprius Technologies by 10.9% during the first quarter. Royal Bank of Canada now owns 101,914 shares of the company’s stock worth $1,718,000 after buying an additional 9,998 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in shares of Amprius Technologies by 76.7% during the first quarter. The Manufacturers Life Insurance Company now owns 58,790 shares of the company’s stock worth $991,000 after buying an additional 25,510 shares in the last quarter. Institutional investors own 5.04% of the company’s stock.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.